Gender-Related Safety and Outcome in Advanced NSCLC Patients Treated with Immune Checkpoint-Inhibitors. A Real-World Experience

被引：0
|
作者：
Pizzutilo, P. [1 ]
Catino, A. [1 ]
Montrone, M. [1 ]
Longo, V. [1 ]
Ricci, D. [1 ]
Pesola, F. [1 ]
Marech, I. [1 ]
Mastrandrea, A. [1 ]
Petrillo, P. [1 ]
Zacheo, A. [1 ]
Varesano, N. [1 ]
Lamorgese, V. [1 ]
Bafunno, D. [1 ]
Galetta, D. [1 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II, Thorac Oncol, Thorac Oncol Unit, Bari, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Immune checkpoint inhibitors; Gender-related outcome; advanced lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75.14
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [1] Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors
    Ariyasu, Ryo
    Kakuto, Sho
    Miyadera, Keiki
    Akita, Takahiro
    Kiritani, Ayu
    Tsugitomi, Ryosuke
    Amino, Yoshiaki
    Uchibori, Ken
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (06):
  • [2] Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia
    Al Nuhait, Mohammed
    Bajnaid, Eshtyag
    Al Otaibi, Abdulmalik
    Al Shammari, Abdullah
    Al Awlah, Yousef
    SCIENCE PROGRESS, 2021, 104 (01)
  • [3] BRAF Mutant NSCLC and Immune Checkpoint Inhibitors: Results From a Real-World Experience
    Rihawi, Karim
    Giannarelli, Diana
    Galetta, Domenico
    Delmonte, Angelo
    Giavarra, Marco
    Turci, Daniele
    Garassino, Marina
    Tiseo, Marcello
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : E57 - E59
  • [4] Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis
    Paderi, Agnese
    Gambale, Elisabetta
    Botteri, Cristina
    Giorgione, Roberta
    Lavacchi, Daniele
    Brugia, Marco
    Mazzoni, Francesca
    Giommoni, Elisa
    Bormioli, Susanna
    Amedei, Amedeo
    Pillozzi, Serena
    Matucci Cerinic, Marco
    Antonuzzo, Lorenzo
    MOLECULES, 2021, 26 (19):
  • [5] Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian center
    Ng, Kennedy
    Wong, Lawrence Wen Jun
    Choo, Su Pin
    Tai, David Wai-Meng
    Tan, Sze Huey
    Ang, Andrea Jing Shi
    Lee, Joycelyn Jie Xin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [6] Real-world efficacy and safety of immune checkpoint inhibitors in advanced hepatocellular carcinoma: Experience of a tertiary Asian Center
    Ng, Kennedy Yao Yi
    Wong, Lawrence Wen Jun
    Ang, Andrea Jing Shi
    Tan, Sze Huey
    Choo, Su Pin
    Tai, David Wai-Meng
    Lee, Joycelyn Jie Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E249 - E261
  • [7] Health-Related Quality of Life in a Real-World Cohort of Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors
    Kobayashi, Hiroki
    Furubayashi, Nobuki
    Morihara, Kaede
    Nakamura, Motonobu
    Negishi, Takahito
    ONCOLOGY, 2025,
  • [8] A Real-World Comparison of the Safety Profile for Immune Checkpoint Inhibitors in Oncology Patients
    Alwhaibi, Abdulrahman
    Alenazi, Miteb A.
    Alghadeer, Sultan
    Mansy, Wael
    Alsaif, Reem A.
    Abualreesh, Nawaf E.
    Alanazi, Rakan J.
    Alroumi, Abdullah
    Alanazi, Saleh A.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
  • [9] IMMUNE-RELATED ADVERSE EVENTS FROM IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A REAL-WORLD EXPERIENCE
    Gampa, Anuhya
    Peeraphatdit, Thoetchai
    Charlton, Michael R.
    Pillai, Anjana A.
    HEPATOLOGY, 2020, 72 : 694A - 695A
  • [10] Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis
    Tsai, Hong-Ming
    Han, Meng-Zhi
    Lin, Yih-Jyh
    Chang, Ting-Tsung
    Chen, Chiung-Yu
    Cheng, Pin-Nan
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Chen, Po-Jun
    Kang, Jui-Wen
    Chiu, Yen-Cheng
    Chiu, Hung-Chih
    Chien, Shih-Chieh
    Kuo, Hsin-Yu
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (07) : 1929 - 1937
12345